Breast Cancer Molecular Diagnostics Market

Global Breast Cancer Molecular Diagnostics Market Size, Trends & Analysis - Forecasts to 2028 By Technology (PCR, NGS, In Situ Hybridization), By Application (Small and Medium Sized Enterprises, Large Enterprises), By End-user (Hospitals & Clinics, Diagnostic Centres and Medical Laboratories, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on May 12 2024 with the latest and most recent market numbers

Global Breast Cancer Molecular Diagnostics Market Size

The global breast cancer molecular diagnostics market is projected to grow at a CAGR of 15.0% from 2023 to 2028.

Molecular diagnostics are used to identify specific genetic and molecular alterations in cancer cells. This approach helps personalized treatment strategies and improved patient outcomes. Breast cancer is one of the most common cancers, worldwide, the early diagnosis is critical for effective treatment. Rising R&D activities for the molecular mechanisms for breast cancer and the development of advanced diagnostic technologies [such as next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), and in situ hybridization (ISH) techniques] enable the growth in adoption of molecular diagnostics used for breast cancer testing.

Growing incidence of breast cancer, worldwide, will further drive the adoption of molecular diagnostics for breast cancer. Additionally, the need for early cancer diagnosis will also help to drive the market growth. The increasing awareness about the benefits of early detection and accurate diagnosis among medical professionals and patients for effective treatment and improved patient outcomes enhances the market growth. It also plays a major role in identifying specific biomarkers and genetic alterations associated with breast cancer, enabling personalized and targeted therapies. In addition, technological advancements and the availability of molecular diagnostic tools increases the demand of molecular diagnostics used for cancer testing. The technologies (such as NGS and PCR) provide researchers and clinicians with enhanced capabilities to detect genetic mutations, gene expression patterns, and molecular subtypes of breast cancer, that helps in precise diagnosis and treatment selection.

Additionally, the growing emphasis on precision medicine and personalized healthcare will further drive the market demand for breast cancer molecular diagnostics. In line with this, each breast cancer patient has a unique molecular profile, and identifying specific genetic alterations & biomarkers that helps in treatment strategies. Molecular diagnostics helps in identifying potential therapeutic targets, predicting treatment response, and monitoring disease progression, that leads to improved patient management and better clinical outcomes. Moreover, the rising awareness and initiatives for early detection & screening programs contribute to the growth of the breast cancer molecular diagnostics market. Pertaining this trend, governments, healthcare organizations, and advocacy groups are promoting breast cancer screening campaigns that creates a higher demand for accurate & sensitive diagnostic tests. In addition, collaborations and partnerships between academic institutions, research organizations, and diagnostic companies drive R&D activities & the development of novel molecular diagnostic assays.

However, the high cost associated with molecular diagnostics tests for breast cancer is expected to restrain the market growth. In line with this, these tests involve complex technologies and require specialized equipment & skilled personnel, that results in high cost for MDx tests. The high cost also poses challenges for healthcare providers and insurance companies in terms of reimbursement and coverage. Complex testing techniques are the other major challenge in the market. These molecular tests required skilled pathologists/molecular biologists who are trained in analysing genomic data. The shortage of trained personnel and the need for ongoing education & training are expected to hinder the market growth during the forecast period.

global breast cancer molecular diagnostics market

Global Breast Cancer Molecular Diagnostics Market: By Technology

The PCR segment is registered to be the largest segment in the market from 2023-2028. Growing incidence of breast cancer, worldwide, is driving the demand for effective & accurate diagnostic methods, which will in turn increase the adoption of MDx for breast cancer testing. Pertaining to this trend, PCR offers high sensitivity & specificity, making it an invaluable tool for detecting & monitoring genetic alterations in breast cancer cells. Furthermore, the technological advancements and automation have enhanced the efficiency and throughput of PCR assays, that drives the market growth. The real-time PCR and digital PCR techniques has provided faster and more precise quantification of target DNA molecules. Moreover, the development of automated PCR platforms has simplified the testing process, which reduces human error and increasing the scalability of breast cancer molecular diagnostics.

Global Breast Cancer Molecular Diagnostics Market: By Application

The screening segment dominated the breast cancer molecular diagnostics, and is expected to have a high growth rate during the forecast period. This is mainly attributed to the rising awareness about the benefits of early detection and the importance of regular breast cancer screening among both healthcare professionals and the patients. Furthermore, educational campaigns and increased media coverage have helped to promote breast cancer screening as an essential component of women's healthcare, leading to greater acceptance & adoption of molecular diagnostic tests. Additionally, favourable reimbursement policies & government initiatives aimed at promoting breast cancer screening enhanced the market of screening segment of the molecular diagnostics market.

Global Breast Cancer Molecular Diagnostics Market: By End User

The diagnostic centres and medical laboratories segment are registered to be the largest segment in the market from 2023-2028. Also, this is projected to have high growth rate during the forecast period. Technological advancements and the availability of molecular diagnostic tools have enhanced the accuracy and precision of breast cancer testing that helps in high adoption of MDx in diagnostic centres and medical labs. Furthermore, the growing awareness and emphasis on early detection & personalized medicine have fuelled the demand for breast cancer molecular diagnostics in diagnostic centers. Also, growing incidence of breast cancer, coupled with the demand for accurate & timely diagnosis is expected to enhance the growth of diagnostic centers and medical labs segment.

asia pacific breast cancer molecular diagnostics market

Global Breast Cancer Molecular Diagnostics Market: By Region

North America holds the largest share in Breast cancer molecular diagnostics. This is primarily attributed to technological advancements and molecular biology that have revolutionized the field of cancer diagnostics (including breast cancer), this will enhance the market growth across the region. Furthermore, the increasing incidence of breast cancer in North America have provided a growing demand for accurate & early detection methods. Also, the rising awareness among healthcare providers and patients about the benefits of molecular diagnostics in breast cancer management has played a significant role in driving market growth further.
Furthermore, Asia Pacific has witnessed a high growth rate during the forecast period. This is mainly attributed to increasing awareness about breast cancer and the importance of early detection has played a critical role. In line with this, technological advancements and the availability of diagnostic tools have fuelled the growth of the breast cancer molecular diagnostics market in APAC. Also, the rising prevalence of breast cancer in the Asia Pacific has contributed to the market growth.

Global Breast Cancer Molecular Diagnostics Share and Competitor Analysis

Hologic Inc., Genomic Health (Exact Sciences Corporation), BD, Danaher, Koninklijke Philips N.V., QIAGEN, Thermo Fisher Scientific Inc., Myriad Genetics, Argon Medical Devices, Inc., F. Hoffmann-La Roche Ltd., and Illumina, among others, are some of the key players in the global breast cancer molecular diagnostics market.

Please note: This is not an exhaustive list of companies profiled in the report.

1          STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1    Strategic Opportunity & Attractiveness Analysis

1.1.1        Hot Revenue Pockets

1.1.2        Market Attractiveness Score

1.1.3        Revenue Impacting Opportunity

1.1.4        High Growing Region/Country

1.1.5        Competitor Analysis

1.1.6        Consumer Analysis

1.2    Global Market Estimates' View

1.3    Strategic Insights across Business Functions

1.3.1        For Chief Executive Officers

1.3.2        For Chief Marketing Officers

1.3.3        For Chief Strategy Officers

1.4    Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2          TECHNOLOGICAL TRENDS

2.1   Technological Adoption Rate

2.2   Current Trend Impact Analysis

2.3   Future Trend Impact Analysis

2.4   Data Metrics on Feed Stocks

3          GLOBAL MARKET OUTLOOK

3.1   Market Pyramid Analysis

3.1.1        Introduction

3.1.2        Adjacent Market Opportunities

3.1.3        Ancillary Market Opportunities

3.2   Demand Side Analysis

3.2.1        Market Drivers: Impact Analysis

3.2.2        Market Restraints: Impact Analysis

3.2.3        Market Opportunities: Impact Analysis

3.2.4        Market Challenges: Impact Analysis

3.3   Supply Side Analysis

3.3.1        Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2        SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3        Value Chain Analysis

3.3.4        Trend Analysis

3.3.5        Gap Analysis

3.3.6        Cost Analysis

4          GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

4.1   Introduction

4.2   Breast cancer molecular diagnostics market: Technology Scope Key Takeaways

4.3   Revenue Growth Analysis, 2022 & 2028

4.4   PCR

4.4.1        PCR Market Estimates and Forecast, 2020-2028 (USD Million)

4.5   NGS

4.5.1        NGS Market Estimates and Forecast, 2020-2028 (USD Million)

4.6   In Situ Hybridization

4.6.1        In Situ Hybridization Market Estimates and Forecast, 2020-2028 (USD Million)

4.7   Others

4.7.1        Others Market Estimates and Forecast, 2020-2028 (USD Million)

5          GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION

5.1   Introduction

5.2   Breast cancer molecular diagnostics market: Application Scope Key Takeaways

5.3   Revenue Growth Analysis, 2022 & 2028

5.4   Screening

5.4.1        Screening Market Estimates and Forecast, 2020-2028 (USD Million)

5.5   Diagnostic and Predictive

5.5.1        Diagnostic and PredictiveMarket Estimates and Forecast, 2020-2028 (USD Million)

5.6   Others

5.6.1        Others Market Estimates and Forecast, 2020-2028 (USD Million)

6         GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET, BY END-USER

6.1   Introduction

6.2   Breast cancer molecular diagnostics market: End-User Scope Key Takeaways

6.3   Revenue Growth Analysis, 2022 & 2028

6.4   Hospitals & Clinics

6.4.1        Hospitals & Clinics Market Estimates and Forecast, 2020-2028 (USD Million)

6.5   Diagnostic Centers and Medical Laboratories

6.5.1        Manufacturing & Production Market Estimates and Forecast, 2020-2028 (USD Million)

6.6   Others

6.6.1        Others Market Estimates and Forecast, 2020-2028 (USD Million)

7          GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET, BY REGION

7.1   Introduction

7.2   North America Breast Cancer Molecular Diagnostics Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.1        By Technology Type

7.2.2        By Application

7.2.3        By End User  

7.2.4        By Country

7.2.4.1     U.S. Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.1.1           By Technology Type

7.2.4.1.2           By Application

7.2.4.1.3           By End User  

7.2.4.2     Canada Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.2.1           By Technology Type

7.2.4.2.2           By Application

7.2.4.2.3           By End User  

7.2.4.3     Mexico Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.3.1           By Technology Type

7.2.4.3.2           By Application

7.2.4.3.3           By End User  

7.3   Europe Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.3.1        By Technology Type

7.3.2        By Application

7.3.3        By End User  

7.3.4        By Country

7.3.4.1     Germany Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.1.1           By Technology Type

7.3.4.1.2           By Application

7.3.4.1.3           By End User  

7.3.4.2     U.K. Presered Flowers Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.2.1           By Technology Type

7.3.4.2.2           By Application

7.3.4.2.3           By End User  

7.3.4.3     France Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.3.1           By Technology Type

7.3.4.3.2           By Application

7.3.4.3.3           By End User  

7.3.4.4     Italy Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.4.1           By Technology Type

7.3.4.4.2           By Application

7.3.4.4.3           By End User  

7.3.4.5     Spain Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.5.1           By Technology Type

7.3.4.5.2           By Application

7.3.4.5.3           By End User  

7.3.4.6     Netherlands Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.6.1           By Technology Type

7.3.4.6.2           By Application

7.3.4.6.3           By End User  

7.3.4.7     Rest of Europe Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.7.1           By Technology Type

7.3.4.7.2           By Application

7.3.4.7.3           By End User  

7.4   Asia Pacific Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.1        By Technology Type

7.4.2        By Application

7.4.3        By End User  

7.4.4        By Country

7.4.4.1     China Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.1.1           By Technology Type

7.4.4.1.2           By Application

7.4.4.1.3           By End User  

7.4.4.2     Japan Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.2.1           By Technology Type

7.4.4.2.2           By Application

7.4.4.2.3           By End User  

7.4.4.3     India Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.3.1           By Technology Type

7.4.4.3.2           By Application

7.4.4.3.3           By End User  

7.4.4.4     South Korea Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.4.1           By Technology Type

7.4.4.4.2           By Application

7.4.4.4.3           By End User  

7.4.4.5     Singapore Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.5.1           By Technology Type

7.4.4.5.2           By Application

7.4.4.5.3           By End User  

7.4.4.6     Malaysia Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.6.1           By Technology Type

7.4.4.6.2           By Application

7.4.4.6.3           By End User  

7.4.4.7     Thailand Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.7.1           By Technology Type

7.4.4.7.2           By Application

7.4.4.7.3           By End User  

7.4.4.8     Indonesia Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.7.1           By Technology Type

7.4.4.7.2           By Application

7.4.4.7.3           By End User  

7.4.4.9     Vietnam Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.8.1           By Technology Type

7.4.4.8.2           By Application

7.4.4.8.3           By End User  

7.4.4.10  Taiwan Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.9.1           By Technology Type

7.4.4.9.2           By Application

7.4.4.9.3           By End User  

7.4.4.11  Rest of Asia Pacific Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.11.1        By Technology Type

7.4.4.11.2        By Application

7.4.4.11.3        By End User  

7.5   Middle East & Africa Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.5.1        By Technology Type

7.5.2        By Application

7.5.3        By End User  

7.5.4        By Country

7.5.4.1     Saudi Arabia Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.1.1           By Technology Type

7.5.4.1.2           By Application

7.5.4.1.3           By End User  

7.5.4.2     U.A.E. Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.2.1           By Technology Type

7.5.4.2.2           By Application

7.5.4.2.3           By End User  

7.5.4.3     Israel Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.3.1           By Technology Type

7.5.4.3.2           By Application

7.5.4.3.3           By End User  

7.5.4.4     South Africa Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.4.1           By Technology Type

7.5.4.4.2           By Application

7.5.4.4.3           By End User  

7.5.4.5     Rest of Middle East & Africa Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.5.1           By Technology Type

7.5.4.5.2           By Application

7.5.4.5.3           By End User  

7.6   Central & South America Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.6.1        By Technology

7.6.2        By Application

7.6.3        By End User

7.6.4        By Country

7.6.4.1     Brazil Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.1.1           By Technology Type

7.6.4.1.2           By Application

7.6.4.1.3           By End User  

7.6.4.2     Argentina Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.2.1           By Technology Type

7.6.4.2.2           By Application

7.6.4.2.3           By End User  

7.6.4.3     Chile Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.3.1           By Technology Type

7.6.4.3.2           By Application

7.6.4.3.3           By End User  

7.6.4.4     Rest of Central & South America Breast cancer molecular diagnostics market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.4.1           By Technology Type

7.2.4.4.2           By Application

7.2.4.4.3           By End User  

8          COMPETITIVE LANDCAPE

8.1   Company Market Share Analysis

8.2   Four Quadrant Positioning Matrix

8.2.1        Market Leaders

8.2.2        Market Visionaries

8.2.3        Market Challengers

8.2.4        Niche Market Players

8.3   Vendor Landscape

8.3.1        North America

8.3.2        Europe

8.3.3        Asia Pacific

8.3.4        Rest of the World

8.4   Company Profiles  

8.4.1        Hologic Inc.

8.4.1.1 Business Description & Financial Analysis

8.4.1.2 SWOT Analysis

8.4.1.3 Products & Services Offered

8.4.1.4 Strategic Alliances between Business Partners

8.4.2        Genomic Health

8.4.2.1 Business Description & Financial Analysis

8.4.2.2 SWOT Analysis

8.4.2.3 Products & Services Offered

8.4.2.4 Strategic Alliances between Business Partners

8.4.3        BD

8.4.3.1 Business Description & Financial Analysis

8.4.3.2 SWOT Analysis

8.4.3.3 Products & Services Offered

8.4.3.4 Strategic Alliances between Business Partners

8.4.4        Danaher

8.4.4.1 Business Description & Financial Analysis

8.4.4.2 SWOT Analysis

8.4.4.3 Products & Services Offered

8.4.4.4 Strategic Alliances between Business Partners

8.4.5        Koninklijke Philips N.V.

8.4.5.1 Business Description & Financial Analysis

8.4.5.2 SWOT Analysis

8.4.5.3 Products & Services Offered

8.4.5.4 Strategic Alliances between Business Partners

8.4.6        QIAGEN

8.4.6.1 Business Description & Financial Analysis

8.4.6.2 SWOT Analysis

8.4.6.3 Products & Services Offered

8.4.6.4 Strategic Alliances between Business Partners

8.4.7        THERMO FISHER SCIENTIFIC INC.  

8.4.7.1 Business Description & Financial Analysis

8.4.7.2 SWOT Analysis

8.4.7.3 Products & Services Offered

8.4.7.4 Strategic Alliances between Business Partners

8.4.8        Myriad Genetics

8.4.7.1 Business Description & Financial Analysis

8.4.7.2 SWOT Analysis

8.4.7.3 Products & Services Offered

8.4.7.4 Strategic Alliances between Business Partners

8.4.9        Argon Medical Devices, Inc.  

8.4.8.1 Business Description & Financial Analysis

8.4.8.2 SWOT Analysis

8.4.8.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.10       F. Hoffmann-La Roche Ltd.

8.4.9.1 Business Description & Financial Analysis

8.4.9.2 SWOT Analysis

8.4.9.3 Products & Services Offered

8.4.9.4 Strategic Alliances between Business Partners

8.4.11      Other Companies

8.4.11.1 Business Description & Financial Analysis

8.4.11.2 SWOT Analysis

8.4.11.3 Products & Services Offered

8.4.11.4 Strategic Alliances between Business Partners

 

9          RESEARCH METHODOLOGY

9.1   Market Introduction

9.1.1        Market Definition

9.1.2        Market Scope & SegOrchidtation

9.2   Information ProcureOrchidt

9.2.1        Secondary Research

9.2.1.1 Purchased Databases

9.2.1.2 GMEs Internal Data Repository

9.2.1.3 Secondary Resources & Third Party Perspectives

9.2.1.4 Company Information Sources

9.2.2        Primary Research

9.2.2.1 Various APPLICATION of Respondents for Primary Interviews

9.2.2.2 Number of Interviews Conducted throughout the Research Process

9.2.2.3 Primary Stakeholders

9.2.2.4 Discussion Guide for Primary Participants

9.2.3        Expert Panels

9.2.3.1 Expert Panels Across 30+ Industry

9.2.4        Paid Local Experts

9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region

9.3   Market Estimation

9.3.1        Top-Down Approach

9.3.1.1 Macro-Economic Indicators Considered

9.3.1.2 Micro-Economic Indicators Considered

9.3.2        Bottom Up Approach

9.3.2.1 Company Share Analysis Approach

9.3.2.2 Estimation of Potential Product Sales

9.4   Data Triangulation

9.4.1        Data Collection

9.4.2        Time Series, Cross Sectional & Panel Data Analysis

9.4.3        Cluster Analysis

9.5   Analysis and Output

9.5.1        Inhouse AI Based Real Time Analytics Tool

9.5.2        Output From Desk & Primary Research

9.6   Research Assumptions & Limitations

9.7.1        Research Assumptions

9.7.2        Research Limitations

10        COMPETITIVE LANDCAPE

10.1 Company Market Share Analysis

10.2 Four Quadrant Positioning Matrix

10.2.1      Market Leaders

10.2.2      Market Visionaries

10.2.3      Market Challengers

10.2.4      Niche Market Players

10.3 Vendor Landscape

10.3.1      North America

10.3.2      Europe

10.3.3      Asia Pacific

10.3.4      Rest of the World

10.4 Company Profiles  

10.4.1      Hologic Inc.

10.4.1.1           Business Description & Financial Analysis

10.4.1.2           SWOT Analysis

10.4.1.3           Products & Services Offered

10.4.1.4           Strategic Alliances between Business Partners

10.4.2      Genomic Health

10.4.2.1           Business Description & Financial Analysis

10.4.2.2           SWOT Analysis

10.4.2.3           Products & Services Offered

10.4.2.4           Strategic Alliances between Business Partners

10.4.3      BD

10.4.3.1           Business Description & Financial Analysis

10.4.3.2           SWOT Analysis

10.4.3.3           Products & Services Offered

10.4.3.4           Strategic Alliances between Business Partners

10.4.4      Danaher

10.4.4.1           Business Description & Financial Analysis

10.4.4.2           SWOT Analysis

10.4.4.3           Products & Services Offered

10.4.4.4           Strategic Alliances between Business Partners

10.4.5      Koninklijke Philips N.V.

10.4.5.1           Business Description & Financial Analysis

10.4.5.2           SWOT Analysis

10.4.5.3           Products & Services Offered

10.4.5.4           Strategic Alliances between Business Partners

10.4.6      QIAGEN

10.4.6.1           Business Description & Financial Analysis

10.4.6.2           SWOT Analysis

10.4.6.3           Products & Services Offered

10.4.6.4           Strategic Alliances between Business Partners

10.4.7      THERMO FISHER SCIENTIFIC INC.  

10.4.7.1           Business Description & Financial Analysis

10.4.7.2           SWOT Analysis

10.4.7.3           Products & Services Offered

10.4.7.4           Strategic Alliances between Business Partners

10.4.8      Myriad Genetics

10.4.7.1           Business Description & Financial Analysis

10.4.7.2           SWOT Analysis

10.4.7.3           Products & Services Offered

10.4.7.4           Strategic Alliances between Business Partners

10.4.9      Argon Medical Devices, Inc.  

10.4.9.1           Business Description & Financial Analysis

10.4.9.2           SWOT Analysis

10.4.9.3           Products & Services Offered

10.4.9.4           Strategic Alliances between Business Partners

10.4.10     F. Hoffmann-La Roche Ltd.

10.4.10.1 Business Description & Financial Analysis

10.4.10.2 SWOT Analysis

10.4.10.3 Products & Services Offered

10.4.10.4 Strategic Alliances between Business Partners

10.4.11    Other Companies

10.4.11.1 Business Description & Financial Analysis

10.4.11.2 SWOT Analysis

10.4.11.3 Products & Services Offered

10.4.11.4 Strategic Alliances between Business Partners

LIST OF TABLES

1 Global Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Mllion)

2 PCR Market, By Region, 2020-2028 (USD Mllion)       

3 NGS Market, By Region, 2020-2028 (USD Mllion)      

4 In situ hybridization Market, By Region, 2020-2028 (USD Mllion)

5 others Market, By Region, 2020-2028 (USD Mllion)

6 Global Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Mllion)       

7 Screening Market, By Region, 2020-2028 (USD Mllion)       

8 Diagnostic and Predictive Market, By Region, 2020-2028 (USD Mllion)

9 Others Market, By Region, 2020-2028 (USD Mllion)

10 Global Breast cancer molecular diagnostics market, By end-user, 2020-2028 (USD Mllion)

11 Hospitals & Clinics Market, By Region, 2020-2028 (USD Mllion)   

12 Diagnostic Centers and Medical Laboratories Market, By Region, 2020-2028 (USD Mllion)       

13 Others Market, By Region, 2020-2028 (USD Mllion)

14 Regional Analysis, 2020-2028 (USD Mllion)

15 North America Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

16 North America Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

17 North America Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

18 North America Breast cancer molecular diagnostics market, By Country, 2020-2028 (USD Million)

19 U.S Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

20 U.S Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

21 U.S Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

22 Canada Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

23 Canada Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

24 Canada Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

25 Mexico Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

26 Mexico Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

27 Mexico Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

28 Europe Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

29 Europe Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

30 Europe Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

31 Germany Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

32 Germany Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

33 Germany Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

34 UK Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

35 UK Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

36 UK Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

37 France Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

38 France Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

39 France Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

40 Italy Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

41 Italy Breast cancer molecular diagnostics market, By Application Type, 2020-2028 (USD Million)

42 Italy Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

43 Spain Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

44 Spain Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

45 Spain Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

46 Rest Of Europe Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

47 Rest Of Europe Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

48 Rest of Europe Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

49 Asia Pacific Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

50 Asia Pacific Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

51 Asia Pacific Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

52 Asia Pacific Breast cancer molecular diagnostics market, By Country, 2020-2028 (USD Million)

53 China Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

54 China Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

55 China Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

56 India Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

57 India Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

58 India Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

59 Japan Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

60 Japan Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

61 Japan Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

62 South Korea Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

63 South Korea Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

64 South Korea Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

65 Middle East & Africa Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

66 Middle East & Africa Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

67 Middle East & Africa Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

68 Middle East & Africa Breast cancer molecular diagnostics market, By Country, 2020-2028 (USD Million)

69 Saudi Arabia Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

70 Saudi Arabia Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

71 Saudi Arabia Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

72 UAE Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

73 UAE Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

74 UAE Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

75 Central & South America Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

76 Central & South America Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

77 Central & South America Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

78 Central & South America Breast cancer molecular diagnostics market, By Country, 2020-2028 (USD Million)

79 Brazil Breast cancer molecular diagnostics market, By Technology, 2020-2028 (USD Million)

80 Brazil Breast cancer molecular diagnostics market, By Application, 2020-2028 (USD Million)

81 Brazil Breast cancer molecular diagnostics market, By end-User, 2020-2028 (USD Million)

82 Hologic Inc.: Products & Services Offering

83 Genomic Health: Products & Services Offering     

84 BD: Products & Services Offering   

85 Danaher: Products & Services Offering     

86 Koninklijke Philips N.V.: Products & Services Offering     

87 QIAGEN: Products & Services Offering         

88 THERMO FISHER SCIENTIFIC INC.: Products & Services Offering        

89 Myriad Genetics: Products & Services Offering    

90 Argon Medical Devices, Inc.: Products & Services Offering          

91 F. Hoffmann-La Roche Ltd.: Products & Services Offering              

92 Other Companies: Products & Services Offering  

LIST OF FIGURES

1 Global Breast cancer molecular diagnostics market Overview

2 Global Breast cancer molecular diagnostics market Value From 2020-2028 (USD Mllion)

3 Global Breast cancer molecular diagnostics market Share, By Technology (2022)

4 Global Breast cancer molecular diagnostics market Share, By Application (2022)

5 Global Breast cancer molecular diagnostics market Share, By End-User (2022)

6 Global Breast cancer molecular diagnostics market, By Region (Asia Pacific Market)

7 Technological Trends In Global Breast cancer molecular diagnostics market

8 Four Quadrant Competitor Positioning Matrix

9 Impact Of Macro & Micro Indicators On The Market

10 Impact Of Key Drivers On The Global Breast cancer molecular diagnostics market

11 Impact Of Challenges On The Global Breast cancer molecular diagnostics market

12 Porter’s Five Forces Analysis

13 Global Breast cancer molecular diagnostics market: By Technology Scope Key Takeaways

14 Global Breast cancer molecular diagnostics market, By Technology Segment: Revenue Growth Analysis

15 PCR Market, By Region, 2020-2028 (USD Mllion)       

16 NGS Market, By Region, 2020-2028 (USD Mllion)

17 In situ Hybridization Market, By Region, 2020-2028 (USD Mllion)

18 Others Market, By Region, 2020-2028 (USD Mllion)

19 Global Breast cancer molecular diagnostics market: By Application Scope Key Takeaways

20 Global Breast cancer molecular diagnostics market, By Application Segment: Revenue Growth Analysis

21 Screening Market, By Region, 2020-2028 (USD Mllion)          

22 Diagnostic and Predictive Market, By Region, 2020-2028 (USD Mllion)

23 Others Market, By Region, 2020-2028 (USD Mllion)

24 Global Breast cancer molecular diagnostics market: By End-User Scope Key Takeaways

25 Global Breast cancer molecular diagnostics market, By End-User Segment: Revenue Growth Analysis

26 Hospitals & Clinics Market, By Region, 2020-2028 (USD Mllion)      

27 Diagnostic Centers and Medical Laboratories Market, By Region, 2020-2028 (USD Mllion)

28 Others Market, By Region, 2020-2028 (USD Mllion)

29 Regional Segment: Revenue Growth Analysis

30 Global Breast cancer molecular diagnostics market: Regional Analysis

31 North America Breast cancer molecular diagnostics market Overview

32 North America Breast cancer molecular diagnostics market, By Technology

33 North America Breast cancer molecular diagnostics market, By Application

34 North America Breast cancer molecular diagnostics market, By End User

35 North America Breast cancer molecular diagnostics market, By Country

36 U.S. Breast cancer molecular diagnostics market, By Technology

37 U.S. Breast cancer molecular diagnostics market, By Application

38 U.S. Breast cancer molecular diagnostics market, By End User

39 Canada Breast cancer molecular diagnostics market, By Technology

40 Canada Breast cancer molecular diagnostics market, By Application

41 Canada Breast cancer molecular diagnostics market, By End User

42 Mexico Breast cancer molecular diagnostics market, By Technology

43 Mexico Breast cancer molecular diagnostics market, By Application

44 Mexico Breast cancer molecular diagnostics market, By End User

45 Four Quadrant Positioning Matrix

46 Company Market Share Analysis

47 Hologic Inc.: Company Snapshot

48 Hologic Inc.: SWOT Analysis

49 Hologic Inc.: Geographic Presence

50 Genomic Health: Company Snapshot

51 Genomic Health: SWOT Analysis

52 Genomic Health: Geographic Presence

53 BD: Company Snapshot

54 BD: SWOT Analysis

55 BD: Geographic Presence

56 Danaher: Company Snapshot

57 Danaher: Swot Analysis

58 Danaher: Geographic Presence

59 Koninklijke Philips N.V.: Company Snapshot

60 Koninklijke Philips N.V.: SWOT Analysis

61 Koninklijke Philips N.V.: Geographic Presence

62 QIAGEN: Company Snapshot

63 QIAGEN: SWOT Analysis

64 QIAGEN: Geographic Presence

65 THERMO FISHER SCIENTIFIC INC. : Company Snapshot

66 THERMO FISHER SCIENTIFIC INC. : SWOT Analysis

67 THERMO FISHER SCIENTIFIC INC. : Geographic Presence

68 Myriad Genetics: Company Snapshot

69 Myriad Genetics: SWOT Analysis

70 Myriad Genetics: Geographic Presence

71 Argon Medical Devices, Inc.: Company Snapshot

72 Argon Medical Devices, Inc.: SWOT Analysis

73 Argon Medical Devices, Inc.: Geographic Presence

74 F. Hoffmann-La Roche Ltd.: Company Snapshot

75 F. Hoffmann-La Roche Ltd.: SWOT Analysis

76 F. Hoffmann-La Roche Ltd.: Geographic Presence

77 Other Companies: Company Snapshot

78 Other Companies: SWOT Analysis

79 Other Companies: Geographic Presence

The Global Breast Cancer Molecular Diagnostics Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Breast Cancer Molecular Diagnostics Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global breast cancer molecular diagnostics market is projected to grow at a CAGR of 15.0% from 2023 to 2028.
Hologic Inc., Genomic Health (Exact Sciences Corporation), BD, Danaher, Koninklijke Philips N.V., QIAGEN, Thermo Fisher Scientific Inc., Myriad Genetics, Argon Medical Devices, Inc., F. Hoffmann-La Roche Ltd., and Illumina, among others, are some of the key players in the global breast cancer molecular diagnostics market.
The awareness and benefits of early detection of the breast cancer among medical professionals as well as patients is one of the major opportunities in the market. Molecular diagnostic techniques can identify genetic mutations or alterations in breast tissue samples or circulating tumor DNA, enabling the detection of cancer at its earliest stages. Early detection is crucial for improving patient outcomes and increasing survival rates. Furthermore, the development of companion diagnostic tests, that are specifically designed to identify patients who are likely to respond to a particular targeted therapy. With the increasing number of targeted therapies available for breast cancer treatment, companion diagnostics play a crucial role in patient selection and optimizing treatment outcomes.
Growing incidence of breast cancer will enhance the need for cancer diagnosis coupled with increasing adoption of molecular diagnostics for rapid testing enhance the market growth. The increasing awareness about the benefits of early detection and accurate diagnosis are critical for effective treatment and improved patient outcomes. This will in turn drive the market growth. It also plays a major role in identifying specific biomarkers and genetic alterations associated with breast cancer, enabling personalized and targeted therapies. Technological advancements and the availability of molecular diagnostic tools increases the demand of molecular diagnostics used for cancer testing.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius